Trial intelligence / Profile preview

Intrathecal clonidine and baclofen as adjuncts to spinal cord stimulation for therapy-resistant neuropathic pain

2004-002824-16Phase 2Completed

Sponsor
Karolinska University Hospital
Start
Nov 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of clonidine and baclofen in Neuralgia (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Pain intensity on visual analogue scale and Duration of post-stimulatory pain relief. Started Nov 2004; status: completed.

02

Drugs

clonidinebaclofen
03

Conditions

Neuralgia

Beyond the preview

Go deeper on 2004-002824-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002824-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call